+91-62 89 87 84 25

@Royed Updates

Clarification, News & Notifications
10 Mar 2020

What are the countries present in MENA Pharmaceutical Market?

MENA Pharmaceutical Market stands for The Middle East and North Africa pharmaceutical market. MENA pharmaceutical market consists of 19 countries of middle east and North Africa. Let’s first list out what are the the countries are part of the MENA pharmaceutical market.

These are

  1. Algeria
  2. Bahrain
  3. Egypt
  4. Iran
  5. Iraq
  6. Israel
  7. Jordan
  8. Kuwait
  9. Lebanon
  10. Libya
  11. Morocco
  12. Oman
  13. Palestine
  14. Qatar
  15. Saudi Arabia
  16. Syria
  17. Tunisia
  18. United Arab Emirates
  19. Yemen.

Moreover, apart form above 19 countries, another 16 countries are sometimes included depending on usage. These are Afghanistan, Armenia, Azerbaijan, Chad, Comoros, Cyprus, Djibouti, Eritrea, Ethiopia, Georgia, Mali, Mauritania, Niger, Somalia, Sudan, and Turkey. The population of the region is at least 381 million or 6% of the world’s population.

Egypt (94 million), Iran (80 million), and Algeria (40 million) are the most populous countries in the region.

MENA countries

Middle East Drug Regulatory Affairs

Middle East Region

The Middle East is a transcontinental region which includes Western Asia (although generally excluding the Caucasus) and all of Egypt (which is mostly in North Africa). Here are the major countries in Middle East Region.

  1. Bahrain
  2. Egypt
  3. Iran
  4. Iraq
  5. Israel
  6. Jordan
  7. Kuwait
  8. Lebanon
  9. Libya
  10. Oman
  11. Palestine
  12. Qatar
  13. Saudi Arabia
  14. Sudan
  15. Syria
  16. UAE
  17. Yemen

All GCC countries are the part of Middle East region.

Gulf Cooperation Council – GCC countries

GCC stands for Gulf Cooperation Council. GCC political and economic alliance of six Middle Eastern countries—Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. All GCC countries are part of the middle east region. Therefore, GCC countries are also part of the Middle East and also MENA region.

So, MENA region covers all the countries of Middle East and GCC regions also.

GCC drug regulatory affairs

First of all, the Middle-East and North Africa consists of 18 countries from Morocco to Iran. The region has gradually developed its pharma market and more than 140 companies are operating in the region. MENA pharmaceutical market accounts approximately 2% of the world market.

The pharmaceutical sector in the Middle-East and North Africa (MENA) has observed remarkable growth over the last few years. Probably, MENA pharmaceutical market is estimated to reach around US$60 billion by 2025, with US$1.2-billion allocated for the healthcare system in the 2019 budget.

With governments in the region focusing more and more on the well-being of a growing population and enhancing healthcare services, timely and safe delivery of medical supplies and pharmaceuticals products has laid down the promising future for pharmaceutical industry in the region. MENA pharmaceutical market’s growth in the region is largely driven by high population growth, increased life expectancy and the predominance of lifestyle-related diseases such as diabetes, as well as the desire for excellent healthcare services among countries in the region.

Related Courses:

Drug Registration & Regulation in UAE

GCC Drug Regulatory Affairs

Drug Registration & Regulation in Saudi Arbia

Middle East Drug Regulatory Affairs


Leave a Reply

Scale up your knowledge to Next Level with our Free Content

Case studies & Caselets |Simulation based learning | Online self competency assessment tests 

Thank You for Subscription!